Pharma, Non-Profits Ally To Advance TB Drug Combinations
Goal Is Shorter Duration Treatment Regimens
The Project to Accelerate New Treatments for Tuberculosis (PAN-TB) is pulling together philanthropic, non-profit and private sector participants to collaboratively run Phase II trials for five drugs from Janssen, Otsuka, the TB Alliance and the Bill & Melinda Gates Medical Research Institute.
